Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 17;7(3):rkad087.
doi: 10.1093/rap/rkad087. eCollection 2023.

The relationship between HLA-B*51 subtypes, clinical manifestations and severity of Behçet's syndrome: a large Italian cohort study

Pietro Leccese  1 , Maria Carmela Padula  1 , Eustachio Vincenzo Santospirito  2 , Rosa Colucci  2 , Nancy Lascaro  1 , Angela Anna Padula  1 , Salvatore D'Angelo  1
Affiliations

The relationship between HLA-B*51 subtypes, clinical manifestations and severity of Behçet's syndrome: a large Italian cohort study

Pietro Leccese et al. Rheumatol Adv Pract. .

Abstract

Objectives: Behçet's syndrome (BS) is a chronic multisystemic inflammatory disorder of unclear aetiology. The predominant BS susceptibility locus was identified within HLA-B*51. HLA-B*51 subtypes were previously studied as disease susceptibility markers. Few data are now available about the relationship between B*51 subtypes and clinical phenotype. The aim of this study was to genotype HLA-B*51 subtypes in a series of Italian BS patients and to test the association with clinical manifestations and disease severity (Krause's index).

Methods: HLA-B*51 subtype genotyping for 63 alleles (B*51:01-B*51:63) was performed by PCR after DNA extraction from whole blood of BS patients. The correlation of disease clinical manifestations and severity (Krause's index) with the HLA-B*51 allele and its subtypes was analysed.

Results: We enrolled 241 (140 male and 101 female) BS patients, and HLA-B*51 frequency was 62.7% (151 of 241). One hundred and eight of the HLA-B*51-positive patients carried the B*51:01 subtype (108 of 151, 71.5%), 39 of 151 (25.8%) the B*51:08 subtype, 2 of 151 (1.3%) the B*51:02 subtype, 1 of 151 (0.7%) the B*51:05 subtype, and 1 of 151 (0.7%) the B*51:07 subtype. We found that ocular involvement was statistically associated with HLA-B*51 positivity and with B*51:01 and B*51:08 subtypes (P < 0.05). We also found that disease severity was higher in HLA-B*51-positive patients than in negative patients, but without statistical significance (median Krause's index 5.1 vs 4.1, P > 0.05).

Conclusion: Here, we confirm a high frequency of the HLA-B*51 allele in our group of BS patients. B*51:01 and B*51:08 were found to be the most common subtypes, and an association of both subtypes with ocular involvement was also underlined.

Keywords: Behçet’s syndrome; HLA-B*51; genotyping; subtypes.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Relationship between Krause’s severity index and B*51 status
See this image and copyright information in PMC

References

    1. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR.. Behçet’s disease, the silk road and HLA-B51: historical and geographical perspectives. Tissue Antigens 1999;54:213–20. - PubMed
    1. Leccese P, Yazici Y, Olivieri I.. Behcet’s syndrome in nonendemic regions. Curr Opin Rheumatol 2017;29:12–6. - PubMed
    1. Takemoto Y, Naruse T, Namba K. et al. Re-evaluation of heterogeneity in HLA-B510101 associated with Behcet’s disease. Tissue Antigens 2008;72:347–53. - PubMed
    1. Takeno M, Kariyone A, Yamashita N. et al. Excessive function of peripheral blood neutrophils from patients with Behçet’s disease and from HLA-B51 transgenic mice. Arthritis Rheum 1995;38:426–33. - PubMed
    1. Yamashita N. Hyperreactivity of neutrophils and abnormal T cell homeostasis: a new insight for pathogenesis of Behçet’s disease. Int Rev Immunol 1997;14:11–9. - PubMed

LinkOut - more resources